Could Trusting Science Mean Not Trusting Some FDA Decisions? скачать в хорошем качестве

Could Trusting Science Mean Not Trusting Some FDA Decisions?

Dr Caleb Alexander examines the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease. 0:00 Intro 1:48 How do you see this FDA decision influencing, potentially, public confidence in FDA authority and in health care? 3:53 How should the FDA balance the interests of patient advocacy groups and biopharmaceutical managers against public health and safety? 6:03 How should we consider equity as an ethical value in our assessment of aducanumab's costs and benefits? 8:13 How should physicians respond to patients who request aducanumab? 9:39 Do you have any thoughts on the FDA labeling for aducanumab? 12:19 If you were teaching this FDA decision as a case study to students, what would you want them to learn from it? 14:03 Outro